000 | 01858 a2200493 4500 | ||
---|---|---|---|
005 | 20250516015809.0 | ||
264 | 0 | _c20110622 | |
008 | 201106s 0 0 eng d | ||
022 | _a1872-8057 | ||
024 | 7 |
_a10.1016/j.mce.2010.12.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAl-Dujaili, E A S | |
245 | 0 | 0 |
_aLiquorice and glycyrrhetinic acid increase DHEA and deoxycorticosterone levels in vivo and in vitro by inhibiting adrenal SULT2A1 activity. _h[electronic resource] |
260 |
_bMolecular and cellular endocrinology _cApr 2011 |
||
300 |
_a102-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a11-beta-Hydroxysteroid Dehydrogenases _xmetabolism |
650 | 0 | 4 |
_aAdrenal Cortex _xcytology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aColforsin _xpharmacology |
650 | 0 | 4 |
_aDehydroepiandrosterone _xmetabolism |
650 | 0 | 4 |
_aDesoxycorticosterone _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
650 | 0 | 4 |
_aGlycyrrhetinic Acid _xpharmacology |
650 | 0 | 4 |
_aGlycyrrhiza _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aSaliva _xdrug effects |
650 | 0 | 4 |
_aSteroids _xbiosynthesis |
650 | 0 | 4 |
_aSulfotransferases _xantagonists & inhibitors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
650 | 0 | 4 |
_aTritium _xmetabolism |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aKenyon, C J | |
700 | 1 | _aNicol, M R | |
700 | 1 | _aMason, J I | |
773 | 0 |
_tMolecular and cellular endocrinology _gvol. 336 _gno. 1-2 _gp. 102-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mce.2010.12.011 _zAvailable from publisher's website |
999 |
_c20471989 _d20471989 |